Compare Sumitomo Bakelite Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 18.85% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate 18.85% of over the last 5 years
3
Flat results in Jun 26
4
With ROE of 8.06%, it has a attractive valuation with a 1.82 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 624,985 Million (Mid Cap)
23.00
NA
0.00%
-0.28
8.17%
1.80
Revenue and Profits:
Net Sales:
95,211 Million
(Quarterly Results - Jun 2026)
Net Profit:
11,089 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.29%
0%
31.29%
6 Months
36.77%
0%
36.77%
1 Year
59.98%
0%
59.98%
2 Years
102.92%
0%
102.92%
3 Years
15.91%
0%
15.91%
4 Years
74.22%
0%
74.22%
5 Years
55.79%
0%
55.79%
Sumitomo Bakelite Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.49%
EBIT Growth (5y)
18.85%
EBIT to Interest (avg)
61.85
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.88
Tax Ratio
26.97%
Dividend Payout Ratio
34.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.52%
ROE (avg)
7.78%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
1.82
EV to EBIT
15.65
EV to EBITDA
10.95
EV to Capital Employed
2.09
EV to Sales
1.65
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
13.36%
ROE (Latest)
8.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
95,211.00
82,034.00
16.06%
Operating Profit (PBDIT) excl Other Income
17,433.00
12,308.00
41.64%
Interest
148.00
123.00
20.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11,089.00
8,431.00
31.53%
Operating Profit Margin (Excl OI)
143.10%
105.10%
3.80%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 16.06% vs 0.90% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 31.53% vs 29.71% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
319,867.00
304,773.00
4.95%
Operating Profit (PBDIT) excl Other Income
48,747.00
44,805.00
8.80%
Interest
395.00
333.00
18.62%
Exceptional Items
-694.00
-5,517.00
87.42%
Consolidate Net Profit
28,366.00
19,531.00
45.24%
Operating Profit Margin (Excl OI)
107.80%
101.20%
0.66%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 4.95% vs 6.09% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 45.24% vs -10.98% in Mar 2025
About Sumitomo Bakelite Co., Ltd. 
Sumitomo Bakelite Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






